The current situation in the pharmaceutical industry continues to come to a head. Rising costs, unstable supply chains and, last but not least, the energy crisis and stricter sustainability targets pose major challenges for the players involved: Where is Germany heading as a pharmaceutical location? And what innovative approaches to solutions as well as data-based business models does the industry need in order to succeed in the digital and energy transformation?
This is the focus of this year's Handelsblatt Pharma Annual Conference on March 22 and 23 in Düsseldorf. Here, the most important decision-makers in the industry will come together and talk about the top issues that move the sector.
How can energy costs be reduced? How do the new EU taxonomy and its ESG transparency requirements affect the life sciences sector? And what aspects of sustainability are currently driving the industry? These and other questions will be the focus of an exciting panel discussion entitled "Sustainability and ESG in the Life Sciences Sector - Challenges and Approaches" With us: Nicole Wallner, Head of ESG Project Management at Drees & Sommer, Axel Heueis from the Life Sciences Division of Drees & Sommer, and Moritz Schönleber from Handelsblatt.
Look forward to a lively exchange and interesting impulses!